Banner Witcoff Shareholder Mercedes Meyer will participate in a panel discussion on June 25 during the BIO International Convention in San Diego.
The session, Debunking Biopharmaceutical Patent Myths: Evidence-Based Analysis for Innovation Policy, will provide insights into defending evidence-based patent policy against narratives that threaten the innovation ecosystem. Mercedes and her co-panelists will demonstrate how robust patent protection enables both innovation incentives and timely generic competition, while debunking claims that follow-on innovations represent trivial evergreening.
According to its website, The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from around the world. More information can be found here.
Details of Mercedes’ session are available here.
